Newtyn Management, LLC has filed its 13F form on November 14, 2025 for Q3 2025 where it was disclosed a total value porftolio of $598 Million distributed in 33 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Quidel Ortho Corp with a value of $79.5M, Theravance Biopharma, Inc. with a value of $72.3M, United States Cellular Corp with a value of $69.2M, Cannae Holdings, Inc. with a value of $62.5M, and Apartment Investment & Management CO with a value of $61.6M.
Examining the 13F form we can see an increase of $81.1M in the current position value, from $517M to 598M.
Newtyn Management, LLC is based out at New York, NY
Below you can find more details about Newtyn Management, LLC portfolio as well as his latest detailed transactions.
